The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
TWST.COM Logo
  • Home
  • Experts
  • Reports
  • Products
  • News
  • About Us
  • Series
    • General Investing
    • Financial Services
    • Consumer
    • Industry & Services
    • Natural Resources
    • Healthcare
    • Technology
  • Contact Us

Saratoga Investment Corp

Related Interviews

Rising Interest Rates a Double-Edged Sword for BDCs
June 23, 2022
Alexander, Casey

On Balance, Higher Interest Rates Are a Positive for BDC Performance
August 05, 2021
Alexander, Casey

High-Quality, Well-Positioned BDCs More Likely to Get Through the Crisis
August 07, 2020
Alexander, Casey

Selling Within BDCs Opens Investment Opportunities as Fundamentals Remain Solid
May 30, 2014
Alexander, Casey

Interview with the Chairman and CEO: Saratoga Investments Corp. (SAR)
October 28, 2013
Oberbeck, Christian L.

General Finance Corporation - Ronald F. Valenta
October 18, 2011
Valenta, Ronald F.

Cart

Latest News

Titanium Demand is the Start of the New Industrial Expansion in the United States
JPMorgan (NYSE:JPM), Microsoft (NASDAQ:MSFT) and Truist Financial Corporation (NYSE:TFC): Is It Time to Buy Yet?
The First  (NASDAQ:FBMS), Provident Financial Services (NYSE:PFS) and Lakeland Bancorp (NASDAQ:LBAI): Warren Buffett Says Buy When Others Are Fearful

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

Subscribe now!

Sign Up For Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews

Next-Generation Immune-Oncology Drugs Show Early Promise

Matt Phipps

Published March 30, 2023 in Biotechnology and Pharmaceuticals

Companies covered: GMAB JANX) JNJ ABBV SGEN RHHBY KDNY ARGX AMGN PFE

Buy ($25)

High Cost of Funds Presents Critical Challenge for Biotech Sector

Steve Brozak

Published March 30, 2023 in Biotechnology and Pharmaceuticals

Companies covered: LSTA OMER CDTX JNJ RHHBY

Buy ($25)

Interview with the President and CEO: TRACON Pharmaceuticals Inc. (NASDAQ:TCON)

Charles P. Theuer

Published March 30, 2023 in Biotechnology and Pharmaceuticals

Companies covered: TCON

Buy ($25)

Most Popular Reports

Biotechnology and Pharmaceuticals

Published March 30, 2023

Buy ($175)

Industrial Equipment, Aerospace and Defense

Published March 20, 2023

Buy ($175)

Dividend-Oriented Strategies

Published March 05, 2023

Buy ($175)

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Bank of America Corporation
Exxon Mobil Corporation
Dell Inc.
Verizon Communications Inc.
AT&T Inc.

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: TRACON Pharmaceuticals Inc. (NASDAQ:TCON)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Chairman, President and CEO: GeoVax Labs, Inc. (NASDAQ:GOVX)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Uncovering Bargains: Neglected Stocks with Positive Momentum
Portfolio Benefits from Dividend-Paying Global Multinationals
Powerful Metrics: Growing Free Cash Flow and a Strong Balance Sheet
ANALYST INTERVIEWS
Next-Generation Immune-Oncology Drugs Show Early Promise
High Cost of Funds Presents Critical Challenge for Biotech Sector
Pricing Restrictions, Economic Concerns Weigh on Biotech Sector
Subscribe Today!
Since 1963
© The Wall Street Transcript 2016, 2023
Terms and Conditions
Privacy Policy
 
 
https://www.twst.com/wp-admin/admin-ajax.php
  • Join now for free!
  • Already a member?

or create an account with a social network.

Join with Facebook
Join with Twitter
Join with Google
Join now! | Forgot password?

or login using a social network


Log in with Facebook
Log in with Twitter
Log in with Google